Stonepine Capital Management »

Abivax SA F shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $212k 2.5k 84.90
2024-12-31 $110k 15k 7.32

More positions owned by Stonepine Capital Management

Verastem Com New (VSTM)
Adma Biologics (ADMA)
Evolus (EOLS)
Zevra Therapeutics Com New (ZVRA)
Nektar Therapeutics Com New (NKTR)
Day One Biopharmaceuticals I (DAWN)
Xoma Royalty Corporation Com New (XOMA)
ACADIA Pharmaceuticals (ACAD)
Enanta Pharmaceuticals (ENTA)
X4 Pharmaceuticals Com New (XFOR)
Omniab (OABI)
Surrozen Com New (SRZN)
Tela Bio (TELA)
Indivior Ord (INDV)
Abeona Therapeutics Com New (ABEO)

View all positions for Stonepine Capital Management

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Vestal Point Capital
Adage Capital Partners GP
Baker Bros. Advisors
Farallon Capital Management

View all funds holding Abivax SA F